# Liminatus Pharma, Inc.: Form 8-K/A, filed Jun 2, 2025

- Company: [Liminatus Pharma, Inc.](/companies/limn.md) (CIK 1971387)
- Form: 8-K/A
- Filed: 2025-06-02
- Accepted by EDGAR: May 30, 2025, 21:43 ET
- Period: 2025-04-30
- Accession: 0001104659-25-055078
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1971387/000110465925055078/tm2516317d1_8ka.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1971387/000110465925055078/

## Items reported

- Item 2.01: Completion of an acquisition or disposition
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1971387/000110465925055078/tm2516317d1_8ka.htm

Filed Jun 2, 2025.
Source: SEC EDGAR, the filing index for accession 0001104659-25-055078. Last ingested by Listed: Nov 3, 2026, 19:32 ET. No prices; not investment advice.